High-throughput intracellular microrheology: a new tool for cancer research

高通量细胞内微流变学:癌症研究的新工具

基本信息

  • 批准号:
    8079080
  • 负责人:
  • 金额:
    $ 20.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-06-08 至 2012-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cancer mortality and morbidity are critically related to tumor invasion and metastasis in which the molecular mechanisms are poorly understood. Until their etiology is better revealed, attempts to develop new cancer therapeutics would remain empirical. Cell motility, which drives cancer metastasis, involves dynamic and regulated re-arrangements of the cytoskeleton. Our work and that of several other groups have shown that cytoskeleton phenotypes are typically accompanied by drastic changes in the viscoelastic properties of the cytoskeleton, which in turn modulate the ability of the cytoskeleton to generate net pushing forces at the leading edge and allow the cell to change its shape. Changes in cell mechanical properties have long been predicted to correlate with metastatic potential. However, current cell-mechanics approaches suffer from serious drawbacks - including time of measurement, lack of multiplexing, ambiguity of measurements - which prevent a direct test of this important hypothesis. The objective of this study is to: develop a highly-optimized high-throughput ballistic injection nanorheology (htBIN) technological platform to measure the micromechanical properties in cancer cells rapidly (< 30 seconds per cell) and reliably, and to assess these biophysical properties as a function of cell migration and invasion by comparing ovarian cancer cells of low and high invasive nature to normal cells, all obtained from patients at the Johns Hopkins Hospital. The proposed instrument, which is based on multiple-particle microrheology, presents key advantages over current approaches to cell mechanics. Our device will serve as a new tool for cancer research to study cell mechanics in the context of cancer cell migration and adhesion, and may ultimately serve as a diagnostic tool for patients who are at high risk for ovarian cancer, complementing more conventional biomolecular markers of cancer in a clinical setting While our proposed approach to cell mechanics is a priori applicable to detect intracellular mechanical differences in any type of cancer cells, a primary focus of this project is ovarian cancer. Ovarian cancer was selected as the disease model in this study because it represents one of the most aggressive cancers in women.
描述(由申请人提供):癌症的死亡率和发病率与肿瘤侵袭和转移密切相关,其中分子机制知之甚少。在更好地揭示其病因之前,开发新的癌症治疗剂的尝试将仍然是经验性的。驱动癌症转移的细胞运动涉及细胞骨架的动态和调节的重新分配。我们的工作和其他几个组的工作表明,细胞骨架表型通常伴随着细胞骨架的粘弹性特性的急剧变化,这又调节了细胞骨架在领先边缘产生净推力的能力,并允许细胞的形状改变其形状。长期以来,细胞机械性能的变化与转移潜力相关。然而,当前的细胞力学方法遭受了严重的缺点 - 包括测量时间,缺乏多路复用,测量的模棱两可 - 这阻止了对这一重要假设的直接检验。这项研究的目的是:开发一种高度优化的高通量弹道注射纳米流行病学(HTBIN)技术平台,以迅速测量癌细胞中的微机械性能(每个细胞<30秒),并可靠地评估这些生物物理特性,以评估这些生物物理性特性,从而通过比较细胞的功能和较高的ovarian collist of of ovarian collaiss of ovarian癌症细胞,并具有较高的ovarian癌症细胞,并具有较高的性质。霍普金斯医院。所提出的仪器基于多粒子微流变学,比当前的细胞力学方法具有关键优势。我们的设备将作为癌症研究的新工具,在癌细胞迁移和粘附的背景下研究细胞力学,并最终可以作为患有卵巢癌高风险的患者的诊断工具,补充癌症的更常规生物分子标记在临床上的传统生物分子标记,而我们提出的细胞力学方法是对这种癌细胞差异的先验性癌症差异。卵巢癌被选为本研究的疾病模型,因为它代表了女性最具侵略性的癌症之一。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Denis Wirtz其他文献

Denis Wirtz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Denis Wirtz', 18)}}的其他基金

Organ Specific Project
器官特定项目
  • 批准号:
    10531004
  • 财政年份:
    2022
  • 资助金额:
    $ 20.11万
  • 项目类别:
Organ Specific Project
器官特定项目
  • 批准号:
    10708880
  • 财政年份:
    2022
  • 资助金额:
    $ 20.11万
  • 项目类别:
Tech Core 2
技术核心2
  • 批准号:
    10532385
  • 财政年份:
    2021
  • 资助金额:
    $ 20.11万
  • 项目类别:
Center for 3D Imaging in Cancer Cell Biology
癌细胞生物学 3D 成像中心
  • 批准号:
    10375190
  • 财政年份:
    2021
  • 资助金额:
    $ 20.11万
  • 项目类别:
Tech Core 2
技术核心2
  • 批准号:
    10375193
  • 财政年份:
    2021
  • 资助金额:
    $ 20.11万
  • 项目类别:
Center for 3D Imaging in Cancer Cell Biology
癌细胞生物学 3D 成像中心
  • 批准号:
    10532378
  • 财政年份:
    2021
  • 资助金额:
    $ 20.11万
  • 项目类别:
Center for 3D Imaging in Cancer Cell Biology
癌细胞生物学 3D 成像中心
  • 批准号:
    10375191
  • 财政年份:
    2021
  • 资助金额:
    $ 20.11万
  • 项目类别:
3D Whole-Pancreas Analysis of Mouse Models of Pancreatic Cancer
胰腺癌小鼠模型的 3D 全胰腺分析
  • 批准号:
    10830513
  • 财政年份:
    2021
  • 资助金额:
    $ 20.11万
  • 项目类别:
Center for 3D Imaging in Cancer Cell Biology
癌细胞生物学 3D 成像中心
  • 批准号:
    10532377
  • 财政年份:
    2021
  • 资助金额:
    $ 20.11万
  • 项目类别:
Validation of Nuclear Morphology as a Biomarker of Aging and Aging-Related Phenotypes
核形态作为衰老和衰老相关表型生物标志物的验证
  • 批准号:
    10424439
  • 财政年份:
    2018
  • 资助金额:
    $ 20.11万
  • 项目类别:

相似海外基金

Washington University (WU) ROBIN Center: MicroEnvironment and Tumor Effects Of Radiotherapy (METEOR)
华盛顿大学 (WU) 罗宾中心:放射治疗的微环境和肿瘤效应 (METEOR)
  • 批准号:
    10715019
  • 财政年份:
    2023
  • 资助金额:
    $ 20.11万
  • 项目类别:
Computational imaging approaches to personalized gastric cancer treatment
个性化胃癌治疗的计算成像方法
  • 批准号:
    10585301
  • 财政年份:
    2023
  • 资助金额:
    $ 20.11万
  • 项目类别:
Targeting Oncogenic PELP1/SRC-3 Signaling Complexes in ER+ Breast Cancer
靶向 ER 乳腺癌中的致癌 PELP1/SRC-3 信号复合物
  • 批准号:
    10301265
  • 财政年份:
    2023
  • 资助金额:
    $ 20.11万
  • 项目类别:
A novel molecularly targeted theranostic approach via the alphavbeta6 integrin for the detection and treatment of metastatic cancers
一种通过 alphavbeta6 整合素检测和治疗转移性癌症的新型分子靶向治疗诊断方法
  • 批准号:
    10636199
  • 财政年份:
    2023
  • 资助金额:
    $ 20.11万
  • 项目类别:
Project 3: Credentialing CDK 4/6 inhibitors used with radiation as an effective treatment strategy in locally advanced ER+ and TNBC
项目 3:认证 CDK 4/6 抑制剂与放射结合使用作为局部晚期 ER 和 TNBC 的有效治疗策略
  • 批准号:
    10554474
  • 财政年份:
    2023
  • 资助金额:
    $ 20.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了